Diaceutics ( (GB:DXRX) ) just unveiled an announcement.
Diaceutics PLC announced that trustees of its 2020 Employee Benefit Trust have purchased ordinary shares on behalf of several key personnel under the company’s Share Incentive Plan (SIP) schemes. The company has matched these purchases with a 1:1 share award, and following the issuance of new shares, Diaceutics now has a total of 84,798,378 shares in issue. This move is part of their strategy to facilitate employee participation and align interests with shareholders, potentially impacting the company’s market position and stakeholder engagement.
More about Diaceutics
Diaceutics PLC is a leading technology and solutions provider to the pharmaceutical and biotech industry, offering an end-to-end commercialization solution for precision medicines. Their services are enabled by the DXRX platform, known as The Diagnostics Network, which focuses on ensuring patients receive the right tests and therapies to positively impact disease outcomes.
YTD Price Performance: -0.22%
Technical Sentiment Signal: Sell
Current Market Cap: $133.4M
For an in-depth examination of DXRX stock, go to TipRanks’ Stock Analysis page.